Vironil-A Tablet 25 mg contains Tenofovir Alafenamide (TAF), a next-generation antiviral medication used in the treatment of chronic Hepatitis B virus (HBV) infection and as part of combination antiretroviral therapy for HIV-1 infection. TAF is a prodrug of tenofovir that delivers the active compound more efficiently to infected cells, allowing for lower doses and reduced risk of kidney and bone toxicity compared to older formulations.

Vironil-A is particularly suitable for adults requiring effective viral suppression with a safer long-term profile. It helps control viral replication, prevent liver damage, and improve overall health outcomes in patients with HBV or HIV infection.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Tenofovir Alafenamide 25 mg

Mechanism of Action

Tenofovir Alafenamide is converted intracellularly to tenofovir diphosphate, which inhibits viral reverse transcriptase enzymes. By doing so, it:

• Blocks HBV or HIV viral replication

• Reduces viral load in the bloodstream

• Prevents disease progression and organ damage

Compared to older tenofovir formulations, TAF achieves effective antiviral concentrations in target cells at lower systemic exposure, reducing potential kidney and bone side effects.

Indications

Vironil-A Tablet 25 mg is indicated for:

• Chronic Hepatitis B infection in adults

• Part of combination therapy for HIV-1 infection

• Patients requiring a potent antiviral with a safer renal and bone profile

Dosage and Administration

• Recommended dose: 1 tablet orally once daily

• Can be taken with or without food

• Swallow the tablet whole with water

• Maintain consistent daily intake for optimal viral suppression

• Dose adjustments may be required in patients with severe liver or kidney impairment

Benefits of Vironil-A Tablet

• Highly effective in suppressing HBV and HIV viral replication

• Protects the liver and reduces the risk of disease progression

• Safer for kidneys and bones compared to older tenofovir formulations

• Convenient once-daily dosing supports adherence

• Well-tolerated and suitable for long-term antiviral therapy

Possible Side Effects

Vironil-A Tablet is generally well-tolerated. Some patients may experience:

• Nausea or vomiting

• Headache

• Fatigue

• Dizziness

• Mild gastrointestinal disturbances

Serious side effects are rare but require medical attention if symptoms such as severe allergic reactions or kidney problems occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Use only under medical supervision

• Monitor liver and kidney function regularly

• Inform your doctor about other medications to prevent interactions

• Not recommended in patients with hypersensitivity to tenofovir or prodrugs

• Do not discontinue therapy abruptly to avoid viral rebound or resistance

Storage

Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.

Vironil-A Tablet 25 mg offers effective antiviral therapy for chronic Hepatitis B and HIV-1 with improved safety for long-term use. Consistent use under medical supervision helps suppress viral replication, protect organ health, and improve patient outcomes.